Infective Endocarditis Surgery Using Conventional Prosthetic Valves Versus Cryopreserved Aortic Homograft
Launched by CENTRE CARDIOLOGIQUE DU NORD · Feb 14, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The target population enrolled in the study includes patients with aortic-valve endocarditis at risk of embolization, heart failure and uncontrolled infection undergoing AVR with the use of CAH or conventional mechanical or stent xenograft valve prostheses. Individuals were adequately treated per applicable standards, including for the treatment of infection, LV dysfunction and heart failure. Patients enrolled in the studies were NYHA functional class II, III, or outpatient NYHA IV.
Three groups of patients are included in the study. Patients who were managed with CAH, patients who receive...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Duke Criteria
- • Uncontrolled Infection Local abscess Large vegetation False aneurysm, Fistula, Dehiscence of PV
- • Embolism Large vegetation \>10mm, persistent infection
- • Heart Failure Involvement of aortic root, intervalvular fibrosa, pulmonary edema, cardiogenic shock
- Exclusion Criteria :
- • Pediatric
- • Any echocardiographic evidence of absence of IE
About Centre Cardiologique Du Nord
Centre Cardiologique du Nord is a leading cardiac care institution dedicated to advancing cardiovascular health through innovative research and clinical excellence. With a focus on patient-centered care, the center actively participates in clinical trials to evaluate new therapies and interventions aimed at improving heart health outcomes. Leveraging a multidisciplinary team of experienced cardiologists, researchers, and healthcare professionals, the Centre Cardiologique du Nord is committed to contributing to the global medical community's understanding of cardiovascular diseases while ensuring the highest standards of patient safety and ethical practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Denis, , France
Patients applied
Trial Officials
Francesco Nappi, MD
Principal Investigator
Centre Cardiologique du Nord
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials